181 related articles for article (PubMed ID: 30222954)
1. Nicotine enhances alcoholic fatty liver in mice: Role of CYP2A5.
Chen X; Owoseni E; Salamat J; Cederbaum AI; Lu Y
Arch Biochem Biophys; 2018 Nov; 657():65-73. PubMed ID: 30222954
[TBL] [Abstract][Full Text] [Related]
2. Suppressed hepatocyte proliferation via a ROS-HNE-P21 pathway is associated with nicotine- and cotinine-enhanced alcoholic fatty liver in mice.
Chen X; Wang K; Cederbaum AI; Lu Y
Biochem Biophys Res Commun; 2019 Apr; 512(1):119-124. PubMed ID: 30876690
[TBL] [Abstract][Full Text] [Related]
3. Chronic Exposure to E-Cigarettes Elevates CYP2A5 Activity, Protein Expression, and Cotinine-Induced Production of Reactive Oxygen Species in Mice.
Kanamori K; Ahmad SM; Hamid A; Lutfy K
Drug Metab Dispos; 2024 Feb; 52(3):171-179. PubMed ID: 38195520
[TBL] [Abstract][Full Text] [Related]
4. Role of CYP2A5 in the clearance of nicotine and cotinine: insights from studies on a Cyp2a5-null mouse model.
Zhou X; Zhuo X; Xie F; Kluetzman K; Shu YZ; Humphreys WG; Ding X
J Pharmacol Exp Ther; 2010 Feb; 332(2):578-87. PubMed ID: 19923441
[TBL] [Abstract][Full Text] [Related]
5. Alcoholic fatty liver is enhanced in CYP2A5 knockout mice: The role of the PPARα-FGF21 axis.
Chen X; Ward SC; Cederbaum AI; Xiong H; Lu Y
Toxicology; 2017 Mar; 379():12-21. PubMed ID: 28131861
[TBL] [Abstract][Full Text] [Related]
6. Prenatal smoke exposure induces persistent
Lkhagvadorj K; Meyer KF; Verweij LP; Kooistra W; Reinders-Luinge M; Dijkhuizen HW; de Graaf IAM; Plösch T; Hylkema MN
Epigenetics; 2020 Dec; 15(12):1370-1385. PubMed ID: 32573327
[TBL] [Abstract][Full Text] [Related]
7. Postnatal Smoke Exposure Further Increases the Hepatic Nicotine Metabolism in Prenatally Smoke Exposed Male Offspring and Is Linked with Aberrant
Lkhagvadorj K; Zeng Z; Meyer KF; Verweij LP; Kooistra W; Reinders-Luinge M; Dijkhuizen HW; de Graaf IAM; Plösch T; Hylkema MN
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375250
[TBL] [Abstract][Full Text] [Related]
8. The role of CYP2A5 in liver injury and fibrosis: chemical-specific difference.
Hong F; Si C; Gao P; Cederbaum AI; Xiong H; Lu Y
Naunyn Schmiedebergs Arch Pharmacol; 2016 Jan; 389(1):33-43. PubMed ID: 26363552
[TBL] [Abstract][Full Text] [Related]
9. Nicotine metabolism and urinary elimination in mouse: in vitro and in vivo.
Raunio H; Pokela N; Puhakainen K; Rahnasto M; Mauriala T; Auriola S; Juvonen RO
Xenobiotica; 2008 Jan; 38(1):34-47. PubMed ID: 18098062
[TBL] [Abstract][Full Text] [Related]
10. Ethanol induction of CYP2A5: role of CYP2E1-ROS-Nrf2 pathway.
Lu Y; Zhang XH; Cederbaum AI
Toxicol Sci; 2012 Aug; 128(2):427-38. PubMed ID: 22552773
[TBL] [Abstract][Full Text] [Related]
11. Evidence for induced microsomal bilirubin degradation by cytochrome P450 2A5.
Abu-Bakar A; Moore MR; Lang MA
Biochem Pharmacol; 2005 Nov; 70(10):1527-35. PubMed ID: 16183037
[TBL] [Abstract][Full Text] [Related]
12. Alcoholic Liver Disease: from CYP2E1 to CYP2A5.
Leung TM; Lu Y
Curr Mol Pharmacol; 2017; 10(3):172-178. PubMed ID: 26278389
[TBL] [Abstract][Full Text] [Related]
13. Characterization and comparison of nicotine and cotinine metabolism in vitro and in vivo in DBA/2 and C57BL/6 mice.
Siu EC; Tyndale RF
Mol Pharmacol; 2007 Mar; 71(3):826-34. PubMed ID: 17158199
[TBL] [Abstract][Full Text] [Related]
14. Expression of cytochrome P450 2A5 in a glucose-6-phosphate dehydrogenase-deficient mouse model of oxidative stress.
Nichols KD; Kirby GM
Biochem Pharmacol; 2008 Mar; 75(5):1230-9. PubMed ID: 18068688
[TBL] [Abstract][Full Text] [Related]
15. Ethanol induction of CYP2A5: permissive role for CYP2E1.
Lu Y; Zhuge J; Wu D; Cederbaum AI
Drug Metab Dispos; 2011 Feb; 39(2):330-6. PubMed ID: 21051534
[TBL] [Abstract][Full Text] [Related]
16. Nicotine self-administration in mice is associated with rates of nicotine inactivation by CYP2A5.
Siu EC; Wildenauer DB; Tyndale RF
Psychopharmacology (Berl); 2006 Mar; 184(3-4):401-8. PubMed ID: 16485141
[TBL] [Abstract][Full Text] [Related]
17. High-fat diet induces fibrosis in mice lacking CYP2A5 and PPARα: a new model for steatohepatitis-associated fibrosis.
Chen X; Acquaah-Mensah GK; Denning KL; Peterson JM; Wang K; Denvir J; Hong F; Cederbaum AI; Lu Y
Am J Physiol Gastrointest Liver Physiol; 2020 Nov; 319(5):G626-G635. PubMed ID: 32877213
[TBL] [Abstract][Full Text] [Related]
18. Experimental nonalcoholic fatty liver disease in mice leads to cytochrome p450 2a5 upregulation through nuclear factor erythroid 2-like 2 translocation.
Cui Y; Wang Q; Li X; Zhang X
Redox Biol; 2013; 1(1):433-40. PubMed ID: 24191237
[TBL] [Abstract][Full Text] [Related]
19. Expression of cytochrome P450 2A5 in a C57BL/6J mouse model of nonalcoholic fatty liver disease.
Li R; Guo G; Cao Y; Wang Y; Liu F; Zhang X
Pharmacology; 2013; 92(1-2):26-31. PubMed ID: 23867551
[TBL] [Abstract][Full Text] [Related]
20. Interstrain differences in the expression and activity of Cyp2a5 in the mouse liver.
Poça KS; Parente TE; Chagas LF; Leal BS; Leal HS; Paumgartten FJ; De-Oliveira AC
BMC Res Notes; 2017 Mar; 10(1):125. PubMed ID: 28298240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
